AMD’s RDNA 5 Graphics Cards Face Significant Delays Amid Memory Shortages and Rising Component Prices

AMD’s highly anticipated next-generation RDNA 5 graphics architecture may face substantial delays, according to information emerging from the company’s manufacturing partners at Computex 2026. The postponement appears to be driven by ongoing global memory shortages and escalating component prices that have plagued the semiconductor industry throughout the past year. This development marks a significant setback for AMD’s graphics division, which had been positioning RDNA 5 as a major leap forward in GPU performance and efficiency.

The memory shortage affecting AMD’s plans stems from multiple factors converging in the global supply chain. High Bandwidth Memory (HBM) and GDDR7 components, both critical for next-generation graphics cards, have become increasingly scarce as artificial intelligence companies continue to consume vast quantities of advanced memory chips. Data centers and AI training facilities have been prioritizing memory purchases, leaving consumer graphics card manufacturers competing for limited supplies. Industry analysts estimate that memory prices have surged by 30-40% over the past six months alone, fundamentally altering the economics of launching new GPU products.

AMD’s RDNA architecture has evolved significantly since its initial introduction in 2019. The original RDNA design brought substantial improvements in power efficiency compared to the previous GCN architecture, while RDNA 2 introduced hardware-accelerated ray tracing capabilities. RDNA 3, launched in late 2022, pioneered chiplet-based GPU design in consumer graphics cards, separating the Graphics Compute Die from the Memory Cache Dies. RDNA 4, which arrived more recently, refined this approach while delivering meaningful performance-per-watt improvements. Each generation has demonstrated AMD’s commitment to closing the gap with NVIDIA’s dominant position in the discrete GPU market.

The timing of this delay proves particularly challenging for AMD’s competitive positioning. NVIDIA has been aggressively expanding its presence in both the consumer and professional graphics markets, with its Blackwell architecture derivatives expected to maintain technological leadership. Intel, meanwhile, has been steadily improving its Arc graphics lineup, establishing itself as a credible third player in the discrete GPU space. A delayed RDNA 5 launch could allow competitors to solidify their market positions and capture enthusiast consumers who might otherwise wait for AMD’s next-generation offerings.

Partners and board manufacturers attending Computex 2026 expressed concerns about inventory planning and product roadmaps. Companies like ASUS, MSI, Gigabyte, and Sapphire typically begin engineering custom cooling solutions and PCB designs months before a GPU architecture launches. Uncertainty surrounding RDNA 5’s release timeline complicates these preparations, potentially leading to rushed designs or delayed custom card availability even after the reference launch. Some partners reportedly suggested that AMD might release a limited initial lineup before the full RDNA 5 product stack becomes available.

The broader semiconductor industry context adds complexity to AMD’s situation. Following the pandemic-era chip shortage, manufacturers invested heavily in expanding production capacity. However, the rapid rise of generative AI applications created unexpected demand patterns that current capacity struggles to address. TSMC, AMD’s primary manufacturing partner, has been allocating significant wafer production to AI accelerators, potentially limiting availability for consumer GPU production. Meanwhile, memory manufacturers like Samsung, SK Hynix, and Micron have prioritized HBM production for AI applications, where profit margins significantly exceed those of consumer memory products.

AMD has not officially commented on specific timeline changes for RDNA 5, maintaining its standard practice of announcing products closer to launch dates. However, financial analysts have begun adjusting their projections for AMD’s Radeon division, with some suggesting that a delayed RDNA 5 could impact the company’s competitive position heading into 2027. The company’s stock showed modest volatility following the Computex reports, reflecting investor uncertainty about the graphics division’s near-term prospects. Industry observers will be watching closely for any official guidance from AMD regarding its GPU roadmap in upcoming earnings calls or technology events.

For consumers anticipating RDNA 5, the delay presents a familiar dilemma in the PC hardware market. Those seeking immediate upgrades may need to consider current-generation options, while patient enthusiasts might benefit from waiting for what promises to be a significant architectural advancement. AMD has historically delivered compelling value propositions with its Radeon products, and RDNA 5 was expected to continue this tradition with substantial performance improvements and enhanced ray tracing capabilities. The ultimate impact of these delays will depend on how effectively AMD navigates the supply chain challenges while maintaining competitive pricing once products eventually reach the market.